SCHEMBL4654196

SCHEMBL4654196

Cc1c(C(=O)CCOCc2ccccc2)sc2cc(C(F)(F)F)ccc12

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AR P10275 6/20 0.40
MCL1 Q07820 1/20 0.40
SENP5 Q96HI0 1/20 0.39
SENP2 Q9HC62 1/20 0.39
SENP1 Q9P0U3 1/20 0.39
LIPG Q9Y5X9 1/20 0.38
CSNK1D P48730 2/20 0.38
HSD11B1 P28845 1/20 0.38
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
RXRG P48443 1/20 0.36
TSHR P16473 1/20 0.36
ALDH1A1 P00352 1/20 0.35
FFAR4 Q5NUL3 1/20 0.35
GPBAR1 Q8TDU6 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
TACR1 P25103 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4656277 0.83 KDM4E (0.38) CSNK1DHSD11B1ALDH1A1LMNATP53
SCHEMBL14469020 0.83 NOD2 (0.39) LIPGCSNK1DLMNATP53
SCHEMBL4657231 0.81 GSK3B (0.40) CSNK1DHSD11B1LMNATP53
SCHEMBL4655147 0.78 GSK3B (0.38) CSNK1DHSD11B1ALDH1A1LMNATP53
SCHEMBL4655131 0.77 AR (0.38) ARMCL1LIPGCSNK1DTACR1
SCHEMBL2721181 0.75 GPR35 (0.54) MCL1ALDH1A1LMNA
SCHEMBL6840332 0.75 DYRK1A (0.44) MCL1CSNK1DALDH1A1
SCHEMBL717432 0.72 ALDH1A1 (0.48) MCL1CSNK1DALDH1A1LMNATP53
SCHEMBL6840329 0.72 MEN1 (0.40) MCL1CSNK1DALDH1A1
SCHEMBL4654171 0.70 AR (0.34) ARMCL1LIPGTACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740568-B1 BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES USEFUL FOR THE TREATMENT OF CARDIOVASCULAR DISEASE. SMITHKLINE BEECHAM CORP (US) 2008-11-26 EP disclosed
US-20070155805-A1 Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease SMITHKLINE BEECHAM CORPORATION 2007-07-05 US disclosed
US-20070155805-A1 Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease SMITHKLINE BEECHAM CORPORATION 2007-07-05 US disclosed
EP-1740568-A2 BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES USEFUL FOR THE TREATMENT OF CARDIOVASCULAR DISEASE. SMITHKLINE BEECHAM CORPORATION (US) 2007-01-10 EP disclosed
WO-2005077926-A2 BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES USEFUL FOR THE TREATMENT OF CARDIOVASCULAR DISEASE SMITHKLINE BEECHAM CORPORATION (US) 2005-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155805-A1 Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease ABAT, BPTF, TNNT2 AR 2860/4885MCL1 3867/4885SENP5 1522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.